The North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) guideline recommends considering a liver biopsy for children with an increased risk of non-alcoholic fatty liver disease or fibrosis, indicated by hepatomegaly and ALT levels exceeding 80 U/L [28]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.